The Multiplexed Gene Analysis (MGA) Core currently provides Cancer Center members with access to technologies for high-throughput gene expression analysis. These technologies often are associated with considerable infrastructure, cost, quality control and/or complexity, making them difficult to establish in individual laboratories. The MGA Core provides gene expression profiling services using Affymetrix GeneChip ?oligonucleotide microarrays. Services include array hybridization and labeled target preparation from standard (3-5 ug) and small scale (10-30 ng) RNA samples. Array data is directly integrated into the SCC Bioinformatics Core, where data retrieval and data mining tools are made available. Particular emphasis is placed on data quality assurance and sample tracking. The MGA Core also provides quantitative (real-time) RT-PCR services. Investigators may elect to prepare their own assays that are then submitted to the Core for analysis. Alternatively, using commercially available, pre-validated primer sets, the Core will perform all steps of the gene expression assay with RNA provided by the investigator. In the future, array-based and PCR-based SNP assays will be supported on the Core's existing technology platforms. Within the past year, the Core has generated gene expression data for over forty cancer center member projects, thus continuing to be a significant technical resource for both basic and translational cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA091842-06
Application #
7287733
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
6
Fiscal Year
2006
Total Cost
$90,024
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Betleja, Ewelina; Nanjundappa, Rashmi; Cheng, Tao et al. (2018) A novel Cep120-dependent mechanism inhibits centriole maturation in quiescent cells. Elife 7:
Chen, Li-Shiun; Horton, Amy; Bierut, Laura (2018) Pathways to precision medicine in smoking cessation treatments. Neurosci Lett 669:83-92
Celik, Hamza; Koh, Won Kyun; Kramer, Ashley C et al. (2018) JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells. Cancer Cell 34:741-756.e8
Olfson, Emily; Bloom, Joseph; Bertelsen, Sarah et al. (2018) CYP2A6 metabolism in the development of smoking behaviors in young adults. Addict Biol 23:437-447
Hirbe, Angela C; Jennings, Jack; Saad, Nael et al. (2018) A Phase II Study of Tumor Ablation in Patients with Metastatic Sarcoma Stable on Chemotherapy. Oncologist 23:760-e76
Jenkins, Wiley D; Gilbert, David; Chen, Li-Shiun et al. (2018) Finding paths with the greatest chance of success: enabling and focusing lung cancer screening and cessation in resource-constrained areas. Transl Lung Cancer Res 7:S261-S264
Kabir, Ashraf Ul; Lee, Tae-Jin; Pan, Hua et al. (2018) Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis. JCI Insight 3:
Smith, Lee; Ae Lee, Jung; Mun, Junbae et al. (2018) Levels and patterns of self-reported and objectively-measured free-living physical activity among prostate cancer survivors: A prospective cohort study. Cancer :
Burclaff, Joseph; Mills, Jason C (2018) Plasticity of differentiated cells in wound repair and tumorigenesis, part II: skin and intestine. Dis Model Mech 11:
Cherian, Mathew A; Olson, Sydney; Sundaramoorthi, Hemalatha et al. (2018) An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia. J Biol Chem 293:6844-6858

Showing the most recent 10 out of 1244 publications